Cellular-based immunotherapies for patients with glioblastoma multiforme
Treatment of patients with glioblastoma multiforme (GBM) remains to be a challenge with a median survival of 14.6 months following diagnosis. Standard treatment options include surgery, radiation therapy, and systemic chemotherapy with temozolomide. Despite the fact that the brain constitutes an imm...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2012
|
| In: |
Clinical & developmental immunology
|
| ISSN: | 1740-2530 |
| DOI: | 10.1155/2012/764213 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1155/2012/764213 Verlag, Volltext: https://www.hindawi.com/journals/jir/2012/764213/ 
|
| Verfasserangaben: | Xun Xu, Florian Stockhammer and Michael Schmitt |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1582371733 | ||
| 003 | DE-627 | ||
| 005 | 20220815042525.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181029s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1155/2012/764213 |2 doi | |
| 035 | |a (DE-627)1582371733 | ||
| 035 | |a (DE-576)512371733 | ||
| 035 | |a (DE-599)BSZ512371733 | ||
| 035 | |a (OCoLC)1341021994 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Xu, Xun |e VerfasserIn |0 (DE-588)1129123103 |0 (DE-627)883801175 |0 (DE-576)486169960 |4 aut | |
| 245 | 1 | 0 | |a Cellular-based immunotherapies for patients with glioblastoma multiforme |c Xun Xu, Florian Stockhammer and Michael Schmitt |
| 264 | 1 | |c 2012 | |
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 29.10.2018 | ||
| 520 | |a Treatment of patients with glioblastoma multiforme (GBM) remains to be a challenge with a median survival of 14.6 months following diagnosis. Standard treatment options include surgery, radiation therapy, and systemic chemotherapy with temozolomide. Despite the fact that the brain constitutes an immunoprivileged site, recent observations after immunotherapies with lysate from autologous tumor cells pulsed on dendritic cells (DCs), peptides, protein, messenger RNA, and cytokines suggest an immunological and even clinical response from immunotherapies. Given this plethora of immunomodulatory therapies, this paper gives a structure overview of the state-of-the art in the field. Particular emphasis was also put on immunogenic antigens as potential targets for a more specific stimulation of the immune system against GBM. | ||
| 700 | 1 | |a Stockhammer, Florian |d 1972- |e VerfasserIn |0 (DE-588)122180372 |0 (DE-627)081786298 |0 (DE-576)293137196 |4 aut | |
| 700 | 1 | |a Schmitt, Michael |d 1966- |e VerfasserIn |0 (DE-588)133177173 |0 (DE-627)538000600 |0 (DE-576)299672921 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical & developmental immunology |d New York, NY : Hindawi, 2003 |g (2012), Artikel-ID 764213 |h Online-Ressource |w (DE-627)369554876 |w (DE-600)2119272-8 |w (DE-576)273887890 |x 1740-2530 |7 nnas |a Cellular-based immunotherapies for patients with glioblastoma multiforme |
| 773 | 1 | 8 | |g year:2012 |g elocationid:764213 |g extent:15 |a Cellular-based immunotherapies for patients with glioblastoma multiforme |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1155/2012/764213 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.hindawi.com/journals/jir/2012/764213/ |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181029 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 133177173 |a Schmitt, Michael |m 133177173:Schmitt, Michael |d 910000 |d 910100 |e 910000PS133177173 |e 910100PS133177173 |k 0/910000/ |k 1/910000/910100/ |p 3 |y j | ||
| 999 | |a KXP-PPN1582371733 |e 3029951944 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1155/2012/764213"],"eki":["1582371733"]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2012"}],"name":{"displayForm":["Xun Xu, Florian Stockhammer and Michael Schmitt"]},"recId":"1582371733","person":[{"display":"Xu, Xun","given":"Xun","role":"aut","family":"Xu"},{"display":"Stockhammer, Florian","role":"aut","given":"Florian","family":"Stockhammer"},{"family":"Schmitt","role":"aut","given":"Michael","display":"Schmitt, Michael"}],"title":[{"title":"Cellular-based immunotherapies for patients with glioblastoma multiforme","title_sort":"Cellular-based immunotherapies for patients with glioblastoma multiforme"}],"language":["eng"],"physDesc":[{"extent":"15 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"disp":"Cellular-based immunotherapies for patients with glioblastoma multiformeClinical & developmental immunology","recId":"369554876","part":{"year":"2012","extent":"15","text":"(2012), Artikel-ID 764213"},"origin":[{"dateIssuedDisp":"2003-2013","publisher":"Hindawi ; Taylor & Francis","dateIssuedKey":"2003","publisherPlace":"New York, NY ; London [u.a.]"}],"id":{"issn":["1740-2530"],"zdb":["2119272-8"],"eki":["369554876"]},"language":["eng"],"pubHistory":["10.2003 - 2013"],"physDesc":[{"extent":"Online-Ressource"}],"titleAlt":[{"title":"Clinical and developmental immunology"}],"note":["Gesehen am 14.02.2025","Fortsetzung der Druck-Ausgabe","Volltext auch als Teil einer Datenbank verfügbar"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"Clinical & developmental immunology","title":"Clinical & developmental immunology"}]}],"note":["Gesehen am 29.10.2018"]} | ||
| SRT | |a XUXUNSTOCKCELLULARBA2012 | ||